Orally administerable deferasirox formulations are disclosed having reduced release under gastric conditions and fast release at near neutral pH or at neutral pH. The alteration unit alters a first image file stored in a removable storage medium in order to generate a second image file. A suspension element extends between a first end connected to the headset at a first location in front of a user’s first ear when the user is wearing the headset, and a second end connected to the headset at a second location in front of the user’s second ear when the user is wearing the headset. A desired minimum value of electric field at the heart periphery is established. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.